Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06140498 · ClinicalTrials.gov registry record · NA
Effects of Self-Efficacy Ecological Momentary Intervention (EMA) App
A NA study of Self Efficacy, sponsored by The New School.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 1
- Study location
NCT06140498: Completed NA study of Self Efficacy, sponsored by The New School.
NCT06140498 is a NA study of Self Efficacy that has completed, run by The New School. The registered enrollment target is 93 participants, below the 151-participant average among 30 other Self Efficacy trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06140498, a NA study of Self Efficacy, has completed, sponsored by The New School.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 1
- Study location
Study Summary
This "SeApp" study aims to test a self-efficacy Ecological Momentary Intervention (EMI) in healthy students in the context of COVID-19. EMIs are mostly smartphone-based applications that deliver interventions to people while being engaged in their daily life activities. The app harnesses the power of self-efficacy autobiographical memories (e.g. problem-solving memories, memories of success). Ecological Momentary Assessments (EMAs) are also incorporated into the study to capture individuals' feelings, affect, and behavior in real time. Clarification added \[September 2025\]: The record previously showed an incorrect estimated enrollment due to a data entry error. The planned enrollment for this trial was 93, consistent with comparable prior studies, and enrollment was closed when 93 participants had been enrolled.
Primary Outcome
change in general self-efficacy meeasured using the General Self-Efficacy Scale (GSE, 10 items rated on a 4-point Likert scale with higher scores indicating greater levels of self-efficacy; min=10, max=40)
Conditions Studied
Interventions
- BEHAVIORAL Self-Efficacy Training and Ecological Momentary Assessment
- BEHAVIORAL Control intervention: Ecological Momentary Assessment only
Study Locations (1)
New York
- The New School - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2023-03-30 |
| Phase | NA |
What the finished NCT06140498 record still lists
NCT06140498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 151-participant average among 30 other Self Efficacy trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Self Efficacy appearing as the primary indexed condition, and to 2 interventions - of which Self-Efficacy Training and Ecological Momentary Assessment is the first listed.
NCT06140498 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06140498 about?
NCT06140498 is a clinical study titled "Effects of Self-Efficacy Ecological Momentary Intervention (EMA) App". This "SeApp" study aims to test a self-efficacy Ecological Momentary Intervention (EMI) in healthy students in the context of COVID-19. EMIs are mostly smartphone-based applications that deliver interventions to people while being engaged in their daily life activities. The app harnesses the power o...
What is the current status of trial NCT06140498?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2021-11-01. Estimated completion is 2023-03-30.
What conditions does trial NCT06140498 study?
This clinical trial studies the following conditions: Self Efficacy.
What interventions are being tested in trial NCT06140498?
The interventions under investigation include: Self-Efficacy Training and Ecological Momentary Assessment (BEHAVIORAL), Control intervention: Ecological Momentary Assessment only (BEHAVIORAL).
Who is sponsoring clinical trial NCT06140498?
This trial is sponsored by The New School, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06140498 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Self Efficacy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06140498's enrollment target sits among peer trials
93 13th of 30 higher than 18 of 30 other Self Efficacy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Self Efficacy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Health Care Transition Readiness Short-Form Video Intervention
RECRUITING · NA
-
Text-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency
RECRUITING · NA
-
Learning Skills Together Family Caregiver Complex Intervention
RECRUITING · NA
-
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI